Browsing by Author "Ekinci, B"

Now showing 1 - 6 of 6
  • No Thumbnail Available
    Item
    A multicenter randomized trial for the effectiveness of structured discharge and follow-up protocol on readmission rate in COPD patients receiving LTOT/NIV: one-year interim analysis.
    Ergan, B; Goktalay, T; Ergun, P; Yilmaz, D; Ocakli, B; Gurgun, A; Demirci, N; Elverisli, F; Ucar, EY; Durmaz, A; Dilektasli, AG; Aksoy, E; Elmas, F; Kokturk, N; Aytekin, F; Akgun, M; Ozyilmaz, E; Cetinoglu, ED; Tuncay, EA; Tasbakan, S; Balbay, O; Demir, AU; Ergun, R; Savci, S; Karakurt, Z; Ekinci, B; Gemicioglu, B; Yorgancioglu, A
  • No Thumbnail Available
    Item
    Evaluation of asthma and COPD awareness in primary care doctors in Turkey
    Ersu, R; Karakoç, GB; Yildiz, F; Köktürk, N; Mungan, D; Ekinci, B; Gemicioglu, B; Yorgancioglu, AA
    Introduction: Chronic pulmonary diseases cause significant morbidity and mortality. However awareness about the risk factors, symptoms, diagnosis and traetment of these disorders is low among patients and health care providers. Our aim was to evaluate the awareness of asthma and chronic obstructive pulmonary disease among primary care doctors. This study was performed by the national Global Alliance Against Chronic Respiratory Diseases programme. Material and Methods: Primary care doctors employed by the Ministry of Healthy were included to the study. Turkish Statistical Institute randomly selected 680 doctors. Questionnaires evaluating the awareness of asthma and COPD which were developed by the Turkish Thoracic Society COPD and asthma assemblies were completed online by these doctors. Results: 84% of the doctors described asthma as airway obstruction. Dyspnea was reported as the most common symptom of asthma (78.8%) and inspiratory rhonci was reported as the most common physical exam finding (42.3%). Around 50% of doctors thought impairment of pulmonary function tests (PFT) was important for diagnosis and evaluation of severity of asthma while 24.2% thought physical exam was more important. When treatment options were evaluated 87.6% chose inhaled treatment for asthma. COPD was described as bronchiectasis and chronic bronchitis by 9.1%, chronic bronchitis and emphysema by 61.6%, chronic bronchitis and asthma by 22.2% and asthma and emphysema by 7.1%. 1.2% of the doctors did not consider cigarette smoking as a risk factor for COPD. PFT was recommended for diagnosis by 83%. Most correctly differentiated asthma and COPD. Bronchodilators were the first choice for COPD by 72.5%. Conclusion: Awareness is low for asthma and COPD among primary care doctors. Awareness should be raised among health care professionals for these diseases with high economical burden to improve outcome.
  • No Thumbnail Available
    Item
    Asthma in the context of global alliance against respiratory diseases (GARD) in Turkey
    Yorgancioglu, A; Gemicioglu, B; Ekinci, B; Özkan, Z; Bayram, H; Ergan, B; Ersu, R; Kocabas, A; Köktürk, N
  • No Thumbnail Available
    Item
    The evaluation of asthma and COPD awareness in Turkey (GARD Turkey Project-National Control Program of Chronic Airway Diseases)
    Yildiz, F; Karakoç, GB; Hamutçu, RE; Yardim, N; Ekinci, B; Yorgancioglu, A
    Introduction: Although chronic respiratory disorders are important causes of morbidity and mortality, health care workers, patients and caretakers are not well informed about these disorders. Therefore these problems are underdiagnosed and undertreated; also preventive measures are not widely taken. Our aim was to evaluate the knowledge of asthma and chronic obstructive pulmonary disease (COPD) in Turkey. This study was designed and performed as a Global Alliance Against Respiratory Disorders (GARD) project. Materials and Methods: People greater than 15 years of age who lived in cities with a population of 200 or greater were eligible for the study. A questionnaire including demographic data and questions regarding asthma and COPD was used for the evalution of the participants. Results: 12.000 people were selected (6000 in rural and 6000 in urban areas); 8527 people were reached. 8342 people who completed the questionnaire were included to the study. There were 4182 (50.1%) female and 4160 (%49.9) male subjects. 49.6% of the subjcets knew that COPD is a lung disease, 51.1% indicated that smoking is the most important risk factor for COPD and 48% identified quitting smoking as the most important preventive measure. Every other person had baseline knowledge on COPD. However only 25.2% knew that there are treatment options for COPD. 80% of subjects said astma can be seen in all age groups. 51.1% knew asthma is a genetic disease and 58% said it is not an infectious disease. However when whether asthma medications caused drug dependency only 27% answered as No while 55.2% said They do not know. Conclusion: Awareness of COPD and asthma seem to be infsufficient among Turkish people. Since these disorders are important causes of morbidity and mortality and have high impact on work and economic loss, it is important to increase knowledge among public.
  • No Thumbnail Available
    Item
    Country activities of Global Alliance against Chronic Respiratory Diseases (GARD): focus presentations at the 11th GARD General Meeting, Brussels
    Bousquet, J; Mohammad, Y; Bedbrook, A; To, T; McGihon, R; Bárbara, C; Melo-Gomes, E; Rosado-Pinto, J; Simao, P; George, F; Punturieri, A; Kiley, JP; Nunes, E; Cossa, A; Camargos, P; Stelmach, R; Cruz, AA; Rostan, MV; Yañez, A; González-Díaz, SN; Urrutia-Pereira, M; Calderon, MA; Gómez, RM; German, Z; Kolek, V; Spicák, V; Lan, LTT; Hurd, S; Lenfant, C; Yorgancioglu, A; Gemicioglu, B; Ekinci, B; Ozkan, Z; Abou Al-Zahab, B; Dmeirieh, A; Shifa, R; Faroun, H; AlJaber, A; Halloum, R; Fatmeh, Y; Alzein, A; Aloush, J; Dib, G; Shaaban, R; Arrais, M; Teixeira, MD; Conceiçao, C; Ferrinho, P
  • No Thumbnail Available
    Item
    THE REFERENCE SITE COLLABORATIVE NETWORK OF THE EUROPEAN INNOVATION PARTNERSHIP ON ACTIVE AND HEALTHY AGEING
    Bousquet, J; Illario, M; Farrell, J; Batey, N; Carriazo, AM; Malva, J; Hajjam, J; Colgan, E; Guldemond, N; Perala-Heape, M; Onorato, GL; Bedbrook, A; Leonardini, L; Stroetman, V; Birov, S; Abreu, C; Abrunhosa, A; Agrimi, A; Alalääkkölä, T; Allegretti, N; Alonso-Trujillo, F; Alvarez-Benito, M; Angioli, S; Apóstolo, J; Armitage, G; Arnavielhe, S; Baena-Parejo, MI; Bamidis, PD; Balenovic, A; Barbolini, M; Baroni, I; Blain, H; Bernard, PL; Bersani, M; Berti, E; Bogatyrchuk, L; Bourret, R; Brehm, J; Brussino, L; Buhr, D; Bultje, D; Cabeza, E; Cano, A; De Capitani, C; Carantoña, E; Cardoso, A; Clavero, JIC; Combe, B; Conforti, D; Coppola, L; Corti, F; Coscioni, E; Costa, E; Crooks, G; Cunha, A; Daien, C; Dantas; Sierra, JD; Davoli, M; Baraldes, AD; De Luca, V; De Nardi, L; Di Ciano, M; Dozet, A; Ekinci, B; Erve, S; Espinoza, AJM; Fait, A; Fensli, R; Nocelo, SF; Gálvez-Daza, P; Gáamez-Payá, J; Sáez, MG; Sanchez, IG; Gemicioglu, B; Goetzke, W; Goossens, E; Geurdens, M; Gütter, Z; Hansen, H; Hartman, S; Hegendörfer, G; Heikka, H; Henderson, D; Héran, D; Hirvonen, S; Iaccarino, G; Jansson, N; Kallasvaara, H; Kalyoncu, F; Kirchmayer, U; Kokko, JA; Korpelainen, J; Kostka, T; Kuna, P; Ortega, TL; Lama, CM; Laune, D; Lauri, D; Ledroit, V; Levato, G; Lewis, L; Liotta, G; Lundgren, L; Lupiañez-Villanueva, F; Mc Garry, P; Maggio, M; de Keenoy, EM; Martinez, C; Martínez-Domene, M; Aranaga, BML; Massimilliano, M; Maurizio, A; Mayora, O; Melle, C; Mendez-Zorilla, A; Mengon, H; Mercier, G; Mercier, J; Meyer, I; Pi-Figueras, AM; Mitsias, P; Molloy, DW; Monti, R; Moro, ML; Muranko, H; Nalin, M; Nobili, A; Noguès, M; O'Caoimh, R; Pais, S; Papini, D; Parkkila, P; Pattichis, C; Pavlickova, A; Peiponen, A; Pereira, S; Pépin, JL; Jiménez, P; Portheine, P; Potel, L; Pozzi, AC; Quiñonez, P; Lauritsen, XR; Ramos, MJ; Rännäli-Kontturi, A; Risino, A; Robalo-Cordeiro, C; Rolla, G; Roller, R; Romano, M; Romano, V; Ruiz-Fernández, J; Saccavini, C; Sachinopoulou, A; Rubio, MJS; Santos, L; Scalvini, S; Scopetani, E; Smedberg, D; Solana-Lara, R; Soltysik, B; Sorlini, M; Stericker, S; Badiale, MS; Taillieu, I; Tervahauta, M; Teixeira, A; Tikanmäki, H; Todo-Bom, A; Tooley, A; Tuulonen, A; Tziraki, C; Ussai, S; Van der Veen, S; Venchiarutti, A; Verdoy-Berastegi, D; Verissimo, M; Visconti, L; Vollenbroek-Hutten, M; Weinzerl, K; Wozniak, L; Yorgancioglu, A; Zavagli, V; Zurkuhlen, AJ
    Seventy four Reference Sites of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA) have been recognised by the European Commission in 2016 for their commitment to excellence in investing and scaling up innovative solutions for active and healthy ageing. The Reference Site Collaborative Network (RSCN) brings together the EIP on AHA Reference Sites awarded by the European Commission, and Candidate Reference Sites into a single forum. The overarching goals are to promote cooperation, share and transfer good practice and solutions in the development and scaling up of health and care strategies, policies and service delivery models, while at the same time supporting the action groups in their work. The RSCN aspires to be recognized by the EU Commission as the principal forum and authority representing all EIP on AHA Reference Sites. The RSCN will contribute to achieve the goals of the EIP on AHA by improving health and care outcomes for citizens across Europe, and the development of sustainable economic growth and the creation of jobs.